Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,009 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis and Clinical Features of Perianal Lesions in Newly Diagnosed Crohn's Disease: Subgroup Analysis from Inception Cohort Registry Study of Patients with Crohn's Disease (iCREST-CD).
Yamamoto T, Nakase H, Watanabe K, Shinzaki S, Takatsu N, Fujii T, Okamoto R, Matsuoka K, Yamada A, Kunisaki R, Matsuura M, Shiga H, Bamba S, Mikami Y, Shimoyama T, Motoya S, Torisu T, Kobayashi T, Ohmiya N, Saruta M, Matsuda K, Matsumoto T, Maemoto A, Murata Y, Yoshigoe S, Nagasaka S, Yajima T, Hisamatsu T; iCREST-CD Study Group. Yamamoto T, et al. Among authors: matsumoto t. J Crohns Colitis. 2023 Aug 21;17(8):1193-1206. doi: 10.1093/ecco-jcc/jjad038. J Crohns Colitis. 2023. PMID: 36869815 Free PMC article.
Use of capsule endoscopy in patients with Crohn's disease in Japan: a multicenter survey.
Esaki M, Matsumoto T, Watanabe K, Arakawa T, Naito Y, Matsuura M, Nakase H, Hibi T, Matsumoto T, Nouda S, Higuchi K, Ohmiya N, Goto H, Kurokawa S, Motoya S, Watanabe M. Esaki M, et al. Among authors: matsumoto t. J Gastroenterol Hepatol. 2014 Jan;29(1):96-101. doi: 10.1111/jgh.12411. J Gastroenterol Hepatol. 2014. PMID: 24354993
Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS).
Nakase H, Hayashi Y, Hirayama D, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Abukawa D, Hisamatsu T; J-COSMOS group. Nakase H, et al. Among authors: matsumoto t. J Gastroenterol. 2022 Mar;57(3):174-184. doi: 10.1007/s00535-022-01851-1. Epub 2022 Jan 28. J Gastroenterol. 2022. PMID: 35089397 Free PMC article.
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
Nakase H, Wagatsuma K, Nojima M, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Takeuchi K, Tamura S, Kinjo F, Ueno N, Naganuma M, Watanabe K, Moroi R, Nishimata N, Motoya S, Kurahara K, Takahashi S, Maemoto A, Sakuraba H, Saruta M, Tominaga K, Hisabe T, Tanaka H, Terai S, Hiraoka S, Takedomi H, Narimatsu K, Endo K, Nakamura M, Hisamatsu T. Nakase H, et al. Among authors: matsumoto t. J Gastroenterol. 2023 Mar;58(3):205-216. doi: 10.1007/s00535-022-01949-6. Epub 2023 Jan 6. J Gastroenterol. 2023. PMID: 36607399 Free PMC article.
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease.
Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. Hibi T, et al. Among authors: matsumoto t. Inflamm Bowel Dis. 2012 Aug;18(8):1480-7. doi: 10.1002/ibd.21886. Epub 2011 Oct 10. Inflamm Bowel Dis. 2012. PMID: 21987418
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease.
Hibi T, Sakuraba A, Watanabe M, Motoya S, Ito H, Sato N, Yoshinari T, Motegi K, Kinouchi Y, Takazoe M, Suzuki Y, Matsumoto T, Kawakami K, Matsumoto T, Hirata I, Tanaka S, Ashida T, Matsui T. Hibi T, et al. Among authors: matsumoto t. J Gastroenterol. 2014 Feb;49(2):254-62. doi: 10.1007/s00535-013-0807-0. Epub 2013 Apr 20. J Gastroenterol. 2014. PMID: 23604570 Clinical Trial.
[Portal venous gas complicated with Crohn's disease. A report of a case].
Fujii K, Nakamura S, Hara J, Kawashima D, Inagawa M, Sogawa M, Iimuro M, Jinno Y, Yamagami H, Watanabe K, Oshitani N, Matsumoto T, Yashiro M, Maeda K, Hirakawa K, Arakawa T. Fujii K, et al. Among authors: matsumoto t. Nihon Shokakibyo Gakkai Zasshi. 2003 Jan;100(1):42-7. Nihon Shokakibyo Gakkai Zasshi. 2003. PMID: 12601927 Review. Japanese. No abstract available.
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.
Ueno F, Matsui T, Matsumoto T, Matsuoka K, Watanabe M, Hibi T; Guidelines Project Group of the Research Group of Intractable Inflammatory Bowel Disease subsidized by the Ministry of Health, Labour and Welfare of Japan and the Guidelines Committee of the Japanese Society of Gastroenterology. Ueno F, et al. Among authors: matsumoto t. J Gastroenterol. 2013 Jan;48(1):31-72. doi: 10.1007/s00535-012-0673-1. Epub 2012 Oct 23. J Gastroenterol. 2013. PMID: 23090001 Free PMC article.
Target biopsy or step biopsy? Optimal surveillance for ulcerative colitis: a Japanese nationwide randomized controlled trial.
Watanabe T, Ajioka Y, Matsumoto T, Tomotsugu N, Takebayashi T, Inoue E, Iizuka B, Igarashi M, Iwao Y, Ohtsuka K, Kudo SE, Kobayashi K, Sada M, Matsumoto T, Hirata I, Murakami K, Nagahori M, Watanabe K, Hida N, Ueno F, Tanaka S, Watanabe M, Hibi T. Watanabe T, et al. Among authors: matsumoto t. J Gastroenterol. 2011 Jan;46 Suppl 1:11-6. doi: 10.1007/s00535-010-0327-0. Epub 2010 Nov 2. J Gastroenterol. 2011. PMID: 21038106 Clinical Trial.
10,009 results
You have reached the last available page of results. Please see the User Guide for more information.